ProCE Banner Activity

Population-Based Study of Pegylated Liposomal Doxorubicin in Patients With Symptomatic Desmoid Tumors

Conference Coverage
Slideset

In a cohort of patients with symptomatic DT, PLD treatment resulted in radiologic response and improvement of symptoms in the majority of patients.

Released: December 18, 2024

Expiration: December 17, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc.